Naperol Investments Ltd
Incorporated in 1954, National Peroxide Ltd is engaged in Investment and Leasing business[1]
- Market Cap ₹ 862 Cr.
- Current Price ₹ 1,500
- High / Low ₹ 2,041 / 801
- Stock P/E 24.3
- Book Value ₹ 1,597
- Dividend Yield 0.00 %
- ROCE 4.88 %
- ROE 3.36 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.94 times its book value
- Company is expected to give good quarter
- Debtor days have improved from 30.5 to 23.5 days.
- Company's working capital requirements have reduced from 103 days to 70.7 days
Cons
- Company has a low return on equity of 2.32% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
155 | 213 | 236 | 197 | 234 | 233 | 306 | 402 | 208 | 227 | 233 | 376 | 380 | |
107 | 146 | 173 | 174 | 197 | 163 | 162 | 175 | 166 | 170 | 209 | 319 | 318 | |
Operating Profit | 48 | 67 | 63 | 22 | 36 | 70 | 144 | 227 | 43 | 57 | 24 | 57 | 62 |
OPM % | 31% | 32% | 27% | 11% | 16% | 30% | 47% | 56% | 21% | 25% | 10% | 15% | 16% |
2 | 5 | 7 | 6 | 7 | -2 | 12 | 19 | 1 | -15 | 10 | 25 | 9 | |
Interest | 0 | 0 | 0 | 5 | 5 | 2 | 1 | 1 | 3 | 13 | 9 | 6 | 5 |
Depreciation | 10 | 11 | 10 | 7 | 9 | 9 | 9 | 9 | 11 | 18 | 17 | 19 | 19 |
Profit before tax | 39 | 61 | 60 | 17 | 29 | 58 | 147 | 236 | 30 | 12 | 8 | 57 | 47 |
Tax % | 29% | 34% | 33% | 60% | 37% | 33% | 35% | 35% | 39% | -72% | 32% | 25% | |
28 | 40 | 40 | 7 | 18 | 39 | 96 | 154 | 18 | 21 | 5 | 43 | 35 | |
EPS in Rs | 48.88 | 70.28 | 70.07 | 11.72 | 32.37 | 67.79 | 168.14 | 269.82 | 31.44 | 37.16 | 9.53 | 74.58 | 62.16 |
Dividend Payout % | 25% | 22% | 22% | 43% | 31% | 51% | 39% | 24% | 40% | 34% | 53% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | 4% |
3 Years: | 22% |
TTM: | 39% |
Compounded Profit Growth | |
---|---|
10 Years: | -3% |
5 Years: | -20% |
3 Years: | 20% |
TTM: | 275% |
Stock Price CAGR | |
---|---|
10 Years: | 13% |
5 Years: | 5% |
3 Years: | 3% |
1 Year: | 51% |
Return on Equity | |
---|---|
10 Years: | 6% |
5 Years: | 5% |
3 Years: | 2% |
Last Year: | 3% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Reserves | 144 | 174 | 204 | 207 | 218 | 736 | 1,011 | 1,168 | 796 | 1,061 | 905 | 905 |
5 | 1 | 4 | 73 | 30 | 11 | 0 | 80 | 161 | 125 | 94 | 14 | |
47 | 57 | 59 | 62 | 60 | 55 | 76 | 88 | 95 | 71 | 63 | 76 | |
Total Liabilities | 202 | 238 | 273 | 348 | 314 | 807 | 1,093 | 1,342 | 1,058 | 1,263 | 1,068 | 1,001 |
118 | 110 | 117 | 187 | 180 | 178 | 170 | 166 | 372 | 342 | 338 | 327 | |
CWIP | 3 | 3 | 41 | 4 | 3 | 2 | 6 | 75 | 0 | 3 | 4 | 3 |
Investments | 25 | 60 | 13 | 13 | 10 | 538 | 762 | 750 | 492 | 746 | 655 | 587 |
57 | 64 | 102 | 144 | 121 | 90 | 156 | 350 | 193 | 172 | 71 | 85 | |
Total Assets | 202 | 238 | 273 | 348 | 314 | 807 | 1,093 | 1,342 | 1,058 | 1,263 | 1,068 | 1,001 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
47 | 42 | 29 | 22 | 22 | 60 | 95 | 148 | 16 | 61 | 9 | 69 | |
-35 | -30 | -22 | -75 | 30 | -33 | -56 | -175 | -39 | -7 | 34 | 26 | |
-12 | -13 | -7 | 54 | -51 | -28 | -35 | 35 | 14 | -49 | -49 | -89 | |
Net Cash Flow | 0 | -1 | 0 | 1 | 0 | -1 | 3 | 8 | -9 | 5 | -6 | 6 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 57 | 54 | 50 | 69 | 51 | 52 | 63 | 28 | 56 | 38 | 30 | 24 |
Inventory Days | 99 | 56 | 134 | 76 | 65 | 66 | 65 | 134 | 98 | 87 | 87 | 73 |
Days Payable | 182 | 175 | 126 | 120 | 83 | 115 | 90 | 101 | 75 | 103 | 41 | 45 |
Cash Conversion Cycle | -25 | -64 | 59 | 25 | 33 | 3 | 39 | 61 | 80 | 23 | 75 | 51 |
Working Capital Days | 49 | 26 | 71 | 150 | 101 | 64 | 115 | 237 | 229 | 197 | 42 | 71 |
ROCE % | 27% | 36% | 30% | 9% | 13% | 13% | 17% | 21% | 3% | 4% | 1% | 5% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 Oct - Copy of Newspaper Advertisements of unaudited financials results for quarter and half year ended September 30, 2024, published in Business Standard (English) and Mumbai Lakshadeep …
-
Appointment of Company Secretary and Compliance Officer
29 Oct - Approval of financial results and new Company Secretary.
- Outcome Of Board Meeting Held On October 29, 2024 29 Oct
-
Board Meeting Outcome for Outcome Of Board Meeting Held On October 29, 2024
29 Oct - Approval of financial results and appointment of Company Secretary.
-
Board Meeting Intimation for Approval Of Unaudited Financial Results For Quarter And Half-Year Ended On September 30, 2024
24 Oct - Board meeting on October 29 to approve financial results.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Services Offered:[1]
a) Manufacturing, distribution and dealing
of peroxygen chemicals
b) Making long term investments and corporate lending directly and/or through its wholly owned subsidiary viz., the Transferor Company.